ACVC Premium Access

Dual or triple antithrombotic therapy?

Event: Acute Cardiovascular Care 2019
Topic: Clinical
Session type: Debate Session
Date: 4 March 2019
Time: 11:00 - 12:30

Congress Session

6 presentations in this session

Positioning of the topic - DAT for all ACS patients with atrial fibrillation receiving coronary stents

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - PRO

Speaker: Doctor A. Sambola (Barcelona, ES)
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - CONTRA

Speaker: Doctor A. Rubboli (Ravenna, IT)
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Rebuttal

Speaker: Doctor A. Rubboli (Ravenna, IT)
Speaker: Doctor A. Sambola (Barcelona, ES)
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Conclusion.

Speaker: Professor P. Clemmensen (Hamburg, DE)
Thumbnail

7 speakers from this session

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

Doctor Antonia Sambola

University Hospital Vall d'Hebron, Barcelona (Spain)
9 presentations
1 follower

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)
12 presentations
0 follower

Doctor Andrea Rubboli

Santa Maria delle Croci Hospital, Ravenna (Italy)
12 presentations
0 follower

Doctor Antonia Sambola

University Hospital Vall d'Hebron, Barcelona (Spain)
9 presentations
1 follower

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

Professor Peter Michael Clemmensen

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
9 presentations
0 follower

This platform is supported by

logo Novo Nordisk